Geneos Wealth Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$883K Buy
8,055
+204
+3% +$29.1K 0.02% 541
2025
Q4
$1.31M Buy
7,851
+381
+5% +$63.7K 0.03% 436
2025
Q3
$1.46M Sell
7,470
-1,450
-16% -$238K 0.04% 405
2025
Q2
$807K Buy
8,920
+582
+7% +$46K 0.02% 587
2025
Q1
$498K Buy
8,338
+8,066
+2,965% +$746K 0.01% 892
2024
Q4
$36K Buy
+272
New +$25.5K ﹤0.01% 1449

Other funds holding ALAB

Geneos Wealth Management's ALAB Position: Q1 2026 in Review

Geneos Wealth Management increased its Astera Labs (ALAB) stake by 2.6% in Q1 2026, buying an estimated $29.1K and bringing the position to 8,055 shares worth $883K. The position accounts for 0.02% of the portfolio, ranked #541.

Geneos Wealth Management first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.46M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Geneos Wealth Management held 8,055 shares of Astera Labs worth $883K as of Q1 2026.
  • Geneos Wealth Management bought 204 Astera Labs shares in Q1 2026, an estimated $29.1K.
  • Astera Labs made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #541 holding.
  • Geneos Wealth Management first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Geneos Wealth Management's Astera Labs position peaked at $1.46M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.